Pirelli & C. S.p.A. (0P1R)
London Exchange · UK · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 6.600 |
|---|---|
| 52-week range | 5.442 – 7.170 |
| Return, 1 month / 3 months | +1.0% / +2.0% |
| Return, 1 year / 3 years | +13.5% / +79.9% |
| Trend | Uptrend |
| RSI (14) | 50 |
| Volatility (1 year) | 21.3% |
| Worst drawdown (1 year) | -14.0% |
| Average daily value traded | 0.30M EUR |
| Dividend yield | 5.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Pirelli & C. S.p.A. is an Italian tyre company based in Milan. It designs and makes tyres for cars, motorcycles and motorsport, with a focus on premium and high-performance products. Its customers include car makers that fit its tyres as original equipment, motorsport teams and organisations, and drivers who replace tyres through dealers and specialist retailers. The company also provides associated services and motorsport tyre supply, and its products are marketed under the Pirelli name across many countries.
Pirelli & C. S.p.A. trades under the code 0P1R on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Pirelli & C. S.p.A. (0P1R) trades on the London Exchange in UK. It last closed at EUR 6.600 on 23 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 601 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 13.5% and over the last three months it rose 2.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 75 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 7.6% | ||
| From 52-week high | -6.1% | ||
| Momentum | 67 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 2.0% | ||
| 6-month return | 16.6% | ||
| 12-month return, skipping the last month | 12.4% | ||
| Stability (higher is calmer) | 86 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.0% | ||
| Liquidity | 41 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.30M EUR | ||
| Zero-volume days | 10.0% | ||
| Income | 59 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.2% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −2.2% |
|---|---|
| 1 month | +1.0% |
| 3 months | +2.0% |
| 6 months | +16.6% |
| 1 year | +13.5% |
| 3 years | +79.9% |
| 5 years | +59.7% |
Signals
| 50-day / 200-day average | 6.567 / 6.136 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.204 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Jul 2026 | EUR 0.3400 |
| 23 Jun 2025 | EUR 0.2500 |
| 24 Jun 2024 | EUR 0.1980 |
| 24 Jul 2023 | EUR 0.2180 |
| 23 May 2022 | EUR 0.1610 |
| 21 Jun 2021 | EUR 0.0800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.